Ken Griffin’s China SXT Pharmaceuticals SXTC Stock Holding History

Ken Griffin’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$241K	–	14193
2025 Q4	$241K	Buy	13 +9	+225%	+$156K	﹤0.01%	10635
2025 Q3	$77.5K	Buy	+4	New	+$79K	﹤0.01%	11993
2024 Q3	–	Hold	0	–	-$17.4K	–	15221
2024 Q2	–	Hold	0	–	–	–	12753
2023 Q4	–	Hold	0	–	-$23.5K	–	15233
2023 Q3	–	Hold	0	–	–	–	12491
2023 Q2	–	Hold	0	–	-$7.02K	–	15220
2023 Q1	–	Hold	0	–	–	–	13762
2022 Q2	–	Hold	0	–	-$75K	–	14070
2022 Q1	–	Hold	0	–	–	–	12526
2021 Q4	–	Hold	0	–	-$11K	–	14730
2021 Q3	–	Hold	0	–	–	–	13681
2021 Q2	–	Hold	0	–	–	–	13352
2021 Q1	–	Hold	0	–	–	–	12485
2020 Q3	–	Hold	0	–	-$7K	–	10710
2020 Q2	–	Hold	0	–	–	–	9661
2020 Q1	–	Hold	0	–	–	–	9371

Other funds holding SXTC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ken Griffin's SXTC Position: Q1 2026 in Review

Ken Griffin sold out of China SXT Pharmaceuticals (SXTC) in Q1 2026, closing a stake of 13 shares — an estimated $241K sold.

Ken Griffin first reported a position in SXTC in Q3 2025 and held it in 2 quarters. The position peaked at $241K in Q4 2025. 1 fund tracked by Wall St. Rank holds SXTC as of Q1 2026.

Ken Griffin reported no remaining China SXT Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Ken Griffin sold 13 China SXT Pharmaceuticals shares in Q1 2026, an estimated $241K.
Ken Griffin first reported a position in China SXT Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Ken Griffin's China SXT Pharmaceuticals position peaked at $241K in Q4 2025.
1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.